443 related articles for article (PubMed ID: 23291443)
1. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
[TBL] [Abstract][Full Text] [Related]
2. [Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis].
Girón RM; Buendía B; Pinedo C; Casanova A; Hoyos N; Ancochea J
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):85-8. PubMed ID: 19254640
[TBL] [Abstract][Full Text] [Related]
3. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
[TBL] [Abstract][Full Text] [Related]
4. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
Maliniak ML; Stecenko AA; McCarty NA
J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
[TBL] [Abstract][Full Text] [Related]
6. Review: Staphylococcus aureus and MRSA in cystic fibrosis.
Goss CH; Muhlebach MS
J Cyst Fibros; 2011 Sep; 10(5):298-306. PubMed ID: 21719362
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.
Harik NS; Com G; Tang X; Melguizo Castro M; Stemper ME; Carroll JL
Am J Infect Control; 2016 Apr; 44(4):409-15. PubMed ID: 26684366
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.
Ahlgren HG; Benedetti A; Landry JS; Bernier J; Matouk E; Radzioch D; Lands LC; Rousseau S; Nguyen D
BMC Pulm Med; 2015 Jun; 15():67. PubMed ID: 26093634
[TBL] [Abstract][Full Text] [Related]
9. The impact of MRSA infection in the airways of children with cystic fibrosis; a case-control study.
Cox DW; Kelly C; Rush R; O'Sullivan N; Canny G; Linnane B
Ir Med J; 2011; 104(10):305-8. PubMed ID: 22256443
[TBL] [Abstract][Full Text] [Related]
10. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
Cios K; Cohen B; Quittell LM; Liu J; Larson EL
Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
[TBL] [Abstract][Full Text] [Related]
11. Treatment intensity and characteristics of MRSA infection in CF.
Muhlebach MS; Miller M; LaVange LM; Mayhew G; Goodrich JS; Miller MB
J Cyst Fibros; 2011 May; 10(3):201-6. PubMed ID: 21420912
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
14. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
15. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
[TBL] [Abstract][Full Text] [Related]
16. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
17. Chest computed tomography scores in patients with cystic fibrosis colonized with methicillin-resistant Staphylococcus aureus.
Gur M; Spinelli E; Tridello G; Baltieri S; Pinali L; Montemezzi S; Bentur L; Assael BM
Clin Respir J; 2018 Feb; 12(2):779-785. PubMed ID: 27925453
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016.
Muhlebach MS; Jiang X; Kosorok MR; Klein EY; Saiman L
J Cyst Fibros; 2022 Jan; 21(1):34-39. PubMed ID: 34456157
[TBL] [Abstract][Full Text] [Related]
20. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
Garske LA; Kidd TJ; Gan R; Bunting JP; Franks CA; Coulter C; Masel PJ; Bell SC
J Hosp Infect; 2004 Mar; 56(3):208-14. PubMed ID: 15003669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
